Q4 Earnings Scorecard And Analyst Reports For NVIDIA, Costco & Stryker
Zacks Investment Research | Feb 20, 2020 04:57AM ET
Thursday, February 20, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Costco Wholesale (COST) and Stryker (SYK). We have also provided a real-time update on the ongoing Q4 earnings season. The research reports featured here have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
Today's Must Read/h6
Featured Reports/h6
Per the Zacks analyst, Advanced Micro Devices is benefiting from robust adoption of latest EYPC, Ryzen and Radeon processors.
Per the Zacks analyst, organic growth remains a key strength at Mitsubishi UFJ. Yet, domestic low rate environment is a woe.
The Zacks analyst is optimistic about CSX's measures to reward shareholders through dividends and share buybacks.
The Zacks analyst expects Boston Scientific to maintain its robust growth momentum across a structural heart and urology arms banking on strong rollout of WATCHMAN, ACURATE and LithoVue.
Per the Zacks analyst, its increasing topline driven by product offerings, geographic expansion and acquisitions has led to significant growth.
Per the Zacks Analyst, buyouts and collaborations have enhanced the company's capabilities, which, in turn, have led to bottom-line growth.
Per the Zacks analyst, well performing Square Register, Build with Square and API platforms continue to aid growth in Square's gross payment volume.
Per the Zacks analyst, Advanced Micro Devices is benefiting from robust adoption of latest EYPC, Ryzen and Radeon processors.
Per the Zacks analyst, organic growth remains a key strength at Mitsubishi UFJ. Yet, domestic low rate environment is a woe.
The Zacks analyst is optimistic about CSX's measures to reward shareholders through dividends and share buybacks.
The Zacks analyst expects Boston Scientific to maintain its robust growth momentum across a structural heart and urology arms banking on strong rollout of WATCHMAN, ACURATE and LithoVue.
Per the Zacks analyst, its increasing topline driven by product offerings, geographic expansion and acquisitions has led to significant growth.
Per the Zacks Analyst, buyouts and collaborations have enhanced the company's capabilities, which, in turn, have led to bottom-line growth.
Per the Zacks analyst, well performing Square Register, Build with Square and API platforms continue to aid growth in Square's gross payment volume.
New Upgrades/h6
Per the Zacks analyst, Micron is benefiting from elevated demand for DRAM products in datacenters, IoT and AI markets. Normalization in customer inventory is a key driver.
Per the Zacks analyst, M&T Bank's continues to gain from increasing loans and deposits balance amid the improving economy. Also, diverse fee income sources will bolster its top line growth.
The Zacks analyst is bullish about new CMS guidance for Omnipod covered under the Medicare Part D prescription drug benefit program.
Per the Zacks analyst, Micron is benefiting from elevated demand for DRAM products in datacenters, IoT and AI markets. Normalization in customer inventory is a key driver.
Per the Zacks analyst, M&T Bank's continues to gain from increasing loans and deposits balance amid the improving economy. Also, diverse fee income sources will bolster its top line growth.
The Zacks analyst is bullish about new CMS guidance for Omnipod covered under the Medicare Part D prescription drug benefit program.
New Downgrades/h6
The Zacks analyst believes that a weak global vehicle production continues to hurt demand for Aptiv's offerings. The company expects global vehicle production to be down 3% in 2020.
Per the Zacks analyst, TreeHouse Foods has been battling with soft sales at its Baked Goods and Meal Solutions units. Evidently, adverse volume/mix hurt sales at these segments in the fourth quarter.
The Zacks analyst is concerned about the below-par rental demand, which is likely to weigh on Ryder's first-quarter 2020 earnings. The company's exorbitant debt levels further add to its woes.
The Zacks analyst believes that a weak global vehicle production continues to hurt demand for Aptiv's offerings. The company expects global vehicle production to be down 3% in 2020.
Per the Zacks analyst, TreeHouse Foods has been battling with soft sales at its Baked Goods and Meal Solutions units. Evidently, adverse volume/mix hurt sales at these segments in the fourth quarter.
The Zacks analyst is concerned about the below-par rental demand, which is likely to weigh on Ryder's first-quarter 2020 earnings. The company's exorbitant debt levels further add to its woes.
Get The News You Want
undefined Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.